This session recorded at CMO Summit 2022 gives CMOs an update on current views on patient-centric medicine development, what it really means and the benefits for both the patient and trial. More specifically:

Achieving timely recruitment by better selecting sites and writing good protocols
Working with patient advocacy groups to integrate patient voice in trial design and drive better enrollment
Achieving enrollment when there is so much competition for patients

Speakers:

Jodie Gillon, MPH, SVP Corporate Affairs & Patient Advocacy, Peptilogics
Barry Ticho, MD, PhD, CMO, Stoke Therapeutics
Rolf Benirschke, Patient Advocate & Former NFL Player, Legacy Health Strategies
Roger Waltzman, MD, MBA, CMO, Molecular Templates

What CMOs Must Know About How Patient Engagement Supports the Entire Biotech

Share

Embed